Loading…
Sanofi Consumer Healthcare India (SANOFICONR)₹3,449−1.36%Pharmaceuticals
At the end of the Jun 2026 quarter, Sanofi Consumer Healthcare India's shareholders were: promoters 71.24%, FIIs 2.59%, DIIs 17.89%, public 8.28%. Promoter holding is unchanged on the quarter. FII holding is down 0.64 percentage points from 3.23% a year earlier. 0.00% of promoter shares were pledged. It had 47,513 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 60.37% | 60.37% | 60.37% | 60.37% | 71.24% | 71.24% | 71.24% | 71.24% | 71.24% |
| FIIs | 6.02% | 5.21% | 4.41% | 4.51% | 3.23% | 2.93% | 2.82% | 2.75% | 2.59% |
| DIIs | 22.64% | 23.87% | 25.39% | 25.52% | 16.93% | 17.25% | 17.37% | 17.61% | 17.89% |
| Public | 10.97% | 10.55% | 9.83% | 9.60% | 8.60% | 8.58% | 8.57% | 8.40% | 8.28% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 61,093 | 58,584 | 55,736 | 51,861 | 49,634 | 48,810 | 48,077 | 48,420 | 47,513 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Opella Healthcare Participations B.V. | Promoter | 60.41% | 0.00 |
| Opal Bidco SAS | Promoter | 10.84% | 0.00 |
| Nippon Life India Trustee Ltd- A/C Nippon India Growth Mid Cap Fund | DII | 5.19% | +0.36 |
| Aditya Birla Sun Life Trustee Private Limited A/C - Aditya Birla Sun Life Large Cap Fund | DII | 3.00% | 0.00 |
| Hdfc Life Insurance Company Limited | DII | 2.13% | +0.84 |
| Icici Prudential Smallcap Fund | DII | 1.58% | +0.01 |
| Sbi Dividend Yield Fund | DII | 1.46% | −0.27 |
| General Insurance Corporation Of India | DII | 1.31% | 0.00 |
| Bajaj Life Insurance Limited | DII | 1.05% | New |
| Bajaj Finserv Flexi Cap Fund | DII | Exited | — |
| Hoechst GMBH | Promoter | 0.00% | 0.00 |
| Sanofi | Promoter | 0.00% | 0.00 |
Promoters held 71.24% of Sanofi Consumer Healthcare India at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 2.59% (down 0.16 percentage points from 2.75% a quarter earlier) and domestic institutions (DIIs) held 17.89% (up 0.28 percentage points from 17.61% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Sanofi Consumer Healthcare India had 47,513 shareholders at the end of the Jun 2026 quarter, against 49,634 a year earlier.
Nippon Life India Trustee Ltd- A/C Nippon India Growth Mid Cap Fund (DII) held 5.19% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.